Deloitte acquires Gryphon Scientific Business to expand security, science and public health capabilities

The acquisition will strengthen Deloitte’s team with a complement of data-driven biosecurity emergency detection, prevention and response solutions.

ARLINGTON, Va., April 292024 /PRNewswire/ — Deloitte announced that it has acquired substantially all of the assets of Gryphon Scientific, LLC (Gryphon), a leader in biosafety, biosecurity and all-hazards preparedness and response with expertise in the use of artificial intelligence (AI) to improve safety and security. Deloitte’s competitive advantage will be strengthened by Gryphon’s multidisciplinary team joining Deloitte, made up of scientists, programmers and policy and planning professionals with expertise in data science, science communications, modeling and risk assessment. Gryphon’s cadre of specialists will enhance Deloitte’s ability to address its clients’ most complex mission challenges, from informing secure policies and practices around new technologies and AI to strengthening capabilities to prevent, detect and respond to infectious disease threats worldwide.

“The addition of Gryphon’s leadership and key professionals to the Deloitte team represents a significant enhancement to Deloitte’s data analytics and advanced technology capabilities. Our federal health practice is excited to lead the way for the U.S. government and public services (GPS) to push the boundaries and bring our customers to the forefront of AI-driven, mission-driven work,” he said Beth Meagher, Principal, Deloitte Consulting LLP and US Federal Healthcare Leader. “This enhances the types of data-driven technology and scientific expertise we can provide to federal agencies and strengthens our ability to support government leaders in their efforts to safeguard our nation’s security and the health and safety of our people.”

For the past two decades, Gryphon has supported government and commercial decision makers in assessing emerging technologies and understanding how to enable the rapid development of these critical tools, while protecting of the associated risks. Gryphon is at the forefront of AI security, particularly understanding how AI can change the risk landscape of biological and chemical threats. Together, Gryphon and Deloitte leaders will continue to develop practical applications of AI in health, foster cross-sector collaboration, and identify and manage risks to build trusted AI solutions through Deloitte’s Federal Health AI Accelerator.

“As leaders in the GPS space for nearly 20 years, we have focused on applying our scientific understanding to prevent and solve complex problems that affect public health and safety,” said Dr. Rocco Casagrande, founder and executive chairman of Gryphon. “Together with Deloitte, we will continue our mission to address some of the most critical life sciences issues facing the world today.”

At Deloitte, Gryphon technical specialists will advance Deloitte’s public health and life sciences preparedness and response capabilities, catalyzing the growth of biosafety, laboratory safety, data science and preparedness and response capabilities Deloitte global and national emergency. Gryphon’s experienced scientists and planning professionals will also help Deloitte clients prepare for biological emergencies and biothreats and strengthen public health and safety across the country.

“We are proud to welcome Gryphon’s talented scientists, data analysts and public health specialists to Deloitte,” he said. Jason Salzetti, Principal, Deloitte Consulting LLP and GPS Industry Leader. “His extensive experience will further strengthen our leadership in artificial intelligence and help our customers address biosecurity threats.”

As used herein, “Deloitte” refers to Deloitte Consulting LLP, a subsidiary of Deloitte LLP. See www.deloitte.com/us/about for a detailed description of our legal structure. Certain services may not be available to certify clients under public accounting rules and regulations.

SOURCE Deloitte